StayWell, Mytonomy Team up to Improve Patient Education

Brian Botos News Releases

News release

(For immediate release)

StayWell, Mytonomy team up to improve patient education

Health care providers will benefit from instant access to extensive library of multi-media patient education materials delivered via the Patient Experience Cloud

Yardley, PA (April 24, 2017) – The StayWell Company and Mytonomy, Inc., two industry leaders that are well-versed in reinventing the patient experience, announced today that they will collaborate to improve the way doctors share information with patients. This arrangement will combine StayWell’s more than 24,000 patient education resources with Mytonomy’s Patient Experience Cloud to facilitate the sharing and utilization of a robust collection — including video, audio and written materials — from one of the nation’s largest patient education providers. In addition, StayWell and Mytonomy will co-market their respective patient education solutions, creating broader access to valuable information that can improve care delivery and patient outcomes.

With innovative solutions like Krames On-Demand, and now with Mytonomy’s Patient Experience Cloud, StayWell has taken the lead in providing hospitals and health systems with multi-media, interactive tools and information to help providers communicate with and engage patients in their care. StayWell solutions support greater interoperability for hospitals and health systems, and align with changing reporting requirements. Mytonomy’s Patient Experience Cloud deepens the value of patient education by helping hospitals and providers deliver a five-star, high-tech and high-touch patient experience.

By working together, the companies hope to streamline patient education, making it easier for people to comply with care plans and doctor’s orders, while delivering real-time utilization and compliance data to clinicians to drive greater operational efficiency and better patient care.

“Consumers are increasingly turning to online, interactive content and videos to learn about everything from fitness and nutrition to do-it-yourself home repair. StayWell capitalizes on leading-edge technologies to deliver educational content to patients in meaningful, powerful ways,” said Nicole Latimer, CEO, StayWell. “Our collaboration with Mytonomy will allow us to connect the dots between our powerful StayWell content and our customer’s most important drivers. In short, we will know who’s engaging with what content and be able to track their behaviors and the impact across the care continuum.”

Hospitals and health systems are likely to benefit from StayWell’s collaboration with Mytonomy in the following ways:

  • Improved utilization tracking for patient education materials;
  • Reduced “no shows” and “cancellations” based on improved patient education;
  • Improved patient experience and satisfaction through hospital-specific wayfinding tools, welcome videos from a patient’s care team and a glimpse into the procedure room;
  • Risk mitigation due to increased standardization;
  • High patient engagement levels and patients likely to refer;
  • Improved patient / clinician interactions;
  • Access to StayWell’s extensive library of patient education tools and Mytonomy’s microlearning patient experience videos with a click of a button; and
  • Connection to social and online media that have become popular sources of consumer health information.

“Patients’ expectations of their health care systems are shaped by their daily experiences as consumers. Our combined Mytonomy and StayWell offering enables systems to drive a significantly better patient experience while providing the right education at the right time for all patients. Health systems that are using our platform find that typically over 70 percent of their patients are using the Mytonomy system across all demographics,” said Anjali Kataria, CEO, Mytonomy. “More patients are arriving on time, are less anxious about their procedures, and their patient satisfaction scores are soaring. In an IRB approved clinical research study, patient satisfaction scores went up to over 95 percent, and the baseline was 70 percent.”

To learn more about the collaboration between StayWell and Mytonomy, contact info@kramesstaywell.com, visit staywell.com and attend a free webinar on May 3 at 2:00 p.m., EST.

###

 About StayWell

StayWell is a health solutions company that uses the science of behavior change to help people live happier, healthier lives. StayWell brings decades of experience working across the health care industry to design solutions for improving individual and organizational health outcomes, managing the health of targeted populations, and creating brand engagement for employers and health care organizations. StayWell programs have received numerous top industry honors, including the C. Everett Koop National Health Award and the Web Health Award for health engagement programs. StayWell also has received URAC and NCQA accreditation for several of its programs. StayWell is majority-owned by Healthcare Services & Solutions, LLC, a wholly owned subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA (“Merck”). The company is headquartered in Yardley, PA, and also has a major location in St. Paul, MN. To learn more, visit http://www.staywell.com.

About Merck

For more than a century, Merck, a leading global biopharmaceutical company known as MSD outside of the United States and Canada, has been inventing for life, bringing forward medicines and vaccines for many of the world’s most challenging diseases. Through our prescription medicines, vaccines, biologic therapies and animal health products, we work with customers and operate in more than 140 countries to deliver innovative health solutions. We also demonstrate our commitment to increasing access to health care through far-reaching policies, programs and partnerships. Today, Merck continues to be at the forefront of research to advance the prevention and treatment of diseases that threaten people and communities around the world – including cancer, cardio-metabolic diseases, emerging animal diseases, Alzheimer’s disease and infectious diseases including HIV and Ebola. For more information, visit www.merck.com and connect with us on Twitter, Facebook, YouTube and LinkedIn.

Forward-Looking Statement of Merck & Co., Inc., Kenilworth, N.J., USA

This news release of The StayWell Company, a subsidiary of Merck & Co., Inc., Kenilworth, N.J., USA (the “company”) includes “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. These statements are based upon the current beliefs and expectations of the company’s management and are subject to significant risks and uncertainties. If underlying assumptions prove inaccurate or risks or uncertainties materialize, actual results may differ materially from those set forth in the forward-looking statements.

Risks and uncertainties include but are not limited to, general industry conditions and competition; general economic factors, including interest rate and currency exchange rate fluctuations; the impact of pharmaceutical industry regulation and health care legislation in the United States and internationally; global trends toward health care cost containment; technological advances, new products and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approval; the company’s ability to accurately predict future market conditions; manufacturing difficulties or delays; financial instability of international economies and sovereign risk; dependence on the effectiveness of the company’s patents and other protections for innovative products; and the exposure to litigation, including patent litigation, and/or regulatory actions.

The company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. Additional factors that could cause results to differ materially from those described in the forward-looking statements can be found in the company’s 2016 Annual Report on Form 10-K and the company’s other filings with the Securities and Exchange Commission (SEC) available at the SEC’s Internet site (www.sec.gov).

About Mytonomy

Mytonomy, Inc., based in Bethesda, MD, is the leader in Patient Experience Cloud Software for hospitals and providers. Mytonomy’s solutions enable hospitals to drive high levels of patient satisfaction and improved patient outcomes through a state-of-the-art patient education, engagement and experience software platform. Hospitals can now tie patient behavior with improved outcomes and metrics. Mytonomy’s founders are ex-Google, FDA, and Oracle execs that bring a wealth of knowledge in consumer experience, learning science and patient engagement, and have combined that with state of the art technology, enabling hospitals to deliver an unparalleled patient experience. The company is headquartered in Bethesda, MD. To learn more, visit http://mytonomy.com/ and follow us on Twitter (@mytonomy).

 

Media contact for StayWell:

Barbara Tabor, APR / 651-230-9192 / barbara@taborPR.com

 

Media contact for Mytonomy:

Ashley Gendron / ashley@mytonomy.com